Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Merola, E; Rinke, A; Partelli, S; Gress, TM; Andreasi, V; Kollár, A; Perren, A; Christ, E; Panzuto, F; Pascher, A; Jann, H; Arsenic, R; Cremer, B; Kaemmerer, D; Kump, P; Lipp, RW; Agaimy, A; Wiedenmann, B; Falconi, M; Pavel, ME.
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Ann Surg Oncol. 2020; 27(5):1348-1355
Doi: 10.1245/s10434-019-08049-5
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Kump Patrizia
- Lipp Rainer
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: While platinum-based chemotherapy represents the standard treatment for advanced grade 3 (G3) neuroendocrine neoplasms (NENs) according to the European Neuroendocrine Tumor Society guidelines, the role of radical-intended surgery in these patients, as well as the use of adjuvant chemotherapy, are still controversial. The aim of the present work is to describe, in a retrospective series of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) G3, the overall survival (OS) rate and risk factors for death after radical surgery. Secondary aims are the description of median recurrence-free survival (RFS) and of the role of adjuvant chemotherapy. PATIENTS AND METHODS: Multicenter analysis of a series of stage I-III GEP-NEN G3 patients receiving radical surgery (R0/R1) with/without adjuvant chemotherapy was performed. RESULTS: Sixty patients from eight neuroendocrine tumor (NET) referral centers, with median follow-up of 23 months (5-187 months) were evaluated. While 28.6% of cases had NET G3, 71.4% had neuroendocrine carcinoma G3 (NEC G3). The 2-year OS rate after radical surgery was 64.5%, with a statistically significant difference in terms of Ki67 threshold (cut-off 55%, P = 0.03) and tumor differentiation (NEC G3 vs. NET G3, P = 0.03). Median RFS after radical surgery was 14 months, and 2-year RFS rate was 44.9%. Use of adjuvant chemotherapy provided no benefit in terms of either OS or RFS in this series. CONCLUSIONS: Surgery with radical intent might represent a valid option for GEP-NEN G3 patients with locoregional disease, especially with Ki67 value ≤ 55%.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Aged - administration & dosage
- Aged, 80 and over - administration & dosage
- Carcinoma, Neuroendocrine - pathology, surgery
- Chemotherapy, Adjuvant - administration & dosage
- Colectomy - administration & dosage
- Colorectal Neoplasms - pathology, surgery
- Digestive System Surgical Procedures - methods
- Disease-Free Survival - administration & dosage
- Esophagectomy - administration & dosage
- Female - administration & dosage
- Gastrectomy - administration & dosage
- Gastrointestinal Neoplasms - pathology, surgery
- Humans - administration & dosage
- Ki-67 Antigen - administration & dosage
- Male - administration & dosage
- Margins of Excision - administration & dosage
- Middle Aged - administration & dosage
- Neoplasm Grading - administration & dosage
- Neoplasm Recurrence, Local - epidemiology
- Neoplasm Staging - administration & dosage
- Neuroendocrine Tumors - pathology, surgery
- Pancreatectomy - administration & dosage
- Pancreatic Neoplasms - pathology, surgery
- Pancreaticoduodenectomy - administration & dosage
- Platinum Compounds - therapeutic use
- Proctectomy - administration & dosage
- Retrospective Studies - administration & dosage
- Survival Rate - administration & dosage